M&A Deal Summary

Cytek Acquires Luminex Corp s Flow Cytometry & Imaging Business

On February 13, 2023, Cytek acquired medical products company Luminex Corp s Flow Cytometry & Imaging Business from Luminex

Acquisition Highlights
  • This is Cytek’s 1st transaction in the Medical Products sector.
  • This is Cytek’s 2nd transaction in the United States.
  • This is Cytek’s 1st transaction in Texas.

M&A Deal Summary
Date 2023-02-13
Target Luminex Corp s Flow Cytometry & Imaging Business
Sector Medical Products
Buyer(s) Cytek
Sellers(s) Luminex
Deal Type Divestiture

Target

Luminex Corp s Flow Cytometry & Imaging Business

Austin, Texas, United States
Luminex Corp's Flow Cytometry & Imaging (FCI) Business gives clients instant access to all facets of cellular phenotypes and morphology. Its microcapillary technology Innovative Guava provides miniaturized systems for quick cell counts, viability, and basic cell health analyses, or step up to the Guava easyCyte System, a versatile benchtop platform for additional, multi-dimensional cell health assessments.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Cytek

Fremont, California, United States
Category Company
Founded 1992
Sector Life Science
Employees645
Revenue 193M USD (2023)
DESCRIPTION

Cytek is a cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling technology. Cytek’s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with exquisite sensitivity. Cytek’s FSP platform includes its core instruments, the Aurora and Northern Lights systems, reagents, cell sorter, software, and services to provide a comprehensive and integrated suite of solutions for its customers. Cytek was founded in 1992 and is based in Fremont, California.

DEAL STATS #
Overall 2 of 2
Sector (Medical Products) 1 of 1
Type (Divestiture) 2 of 2
State (Texas) 1 of 1
Country (United States) 2 of 2
Year (2023) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-11-03 Tonbo Biosciences - Cell Analysis Business

San Diego, California, United States

Tonbo Biosciences' Cell Analysis Business includes an extensive portfolio of life science research reagents related to cell preparation, flow cytometry, molecular immunology/PCR, and cell culture covering application areas across immunology, apoptosis, and immune profiling. Tonbo Biosciences' Cell Analysis Business is based in San Diego, California.

Buy -

Seller(S) 1

SELLER

Luminex

Austin, Texas, United States
Category Company
Founded 1995
Sector Medical Products
Employees1,325
Revenue 417M USD (2020)
DESCRIPTION

Luminex is a developer, manufacturer and marketer of proprietary instruments and assays utilizing xMAP open-architecture, multi-analyte platform and MultiCode real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex was founded in 1995 and is based in Austin, Texas.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 1
State (Texas) 1 of 1
Country (United States) 1 of 1
Year (2023) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-18 Merck KGaA - Flow Cytometry Portfolio

Darmstadt, Germany

Merck KGaA - Flow Cytometry Portfolio includes Amnis, the market-leading family of imaging flow cytometry products for cell-based analysis, as well as their Guava portfolio of products, which are economical, high-performance systems based on microcapillary technologies.

Buy €63M
Mergr

Product

Company

Legal